4HSA image
Deposition Date 2012-10-29
Release Date 2013-05-22
Last Version Date 2024-11-27
Entry Detail
PDB ID:
4HSA
Title:
Structure of interleukin 17a in complex with il17ra receptor
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.15 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Interleukin-17A
Gene (Uniprot):IL17A
Mutations:N45D, C106S
Chain IDs:A, B, D, E
Chain Length:122
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Interleukin-17 receptor A
Gene (Uniprot):IL17RA
Mutations:N175D, N234D
Chain IDs:C, F
Chain Length:301
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN F ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Crystal structures of interleukin 17A and its complex with IL-17 receptor A.
Nat Commun 4 1888 1888 (2013)
PMID: 23695682 DOI: 10.1038/ncomms2880

Abstact

The constituent polypeptides of the interleukin-17 family form six different homodimeric cytokines (IL-17A-F) and the heterodimeric IL-17A/F. Their interactions with IL-17 receptors A-E (IL-17RA-E) mediate host defenses while also contributing to inflammatory and autoimmune responses. IL-17A and IL-17F both preferentially engage a receptor complex containing one molecule of IL-17RA and one molecule of IL-17RC. More generally, IL-17RA appears to be a shared receptor that pairs with other members of its family to allow signaling of different IL-17 cytokines. Here we report crystal structures of homodimeric IL-17A and its complex with IL-17RA. Binding to IL-17RA at one side of the IL-17A molecule induces a conformational change in the second, symmetry-related receptor site of IL-17A. This change favors, and is sufficient to account for, the selection of a different receptor polypeptide to complete the cytokine-receptor complex. The structural results are supported by biophysical studies with IL-17A variants produced by site-directed mutagenesis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures